IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancer-Reference-Cited by-同舟云学术

IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancer

Published:2022-02 Issue:1 Volume:7 Page:100353
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Molinier O.,Besse B.,Barlesi F.,Audigier-Valette C.,Friard S.,Monnet I.,Jeannin G.,Mazières J.,Cadranel J.,Hureaux J.,Hilgers W.,Quoix E.,Coudert B.,Moro-Sibilot D.,Fauchon E.,Westeel V.,Brun P.,Langlais A.,Morin F.,Souquet P.J.,Girard N.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference30 articles.

1. Cancer Statistics, 2021;Siegel;CA Cancer J Clin,2021

2. Lung cancer;Herbst;N Engl J Med,2008

3. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Planchard;Ann Oncol,2019

4. Updated analysis of KEYNOTE-024: pembrolizumab versus platinum-based chemotherapy for advanced non-small-cell lung cancer with PD-L1 tumor proportion score of 50% or greater;Reck;J Clin Oncol,2019

5. Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer;Gandhi;N Engl J Med,2018

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic impact of age in advanced non-small cell lung cancer patients undergoing first-line checkpoint inhibitor immunotherapy and chemotherapy treatment;International Immunopharmacology;2024-05

2. Real-World Data and Evidence in Lung Cancer: A Review of Recent Developments;Cancers;2024-04-04

3. Brain metastases and lung cancer: molecular biology, natural history, prediction of response and efficacy of immunotherapy;Frontiers in Immunology;2024-01-12

4. Immunosenescence and immunotherapy in older NSCLC patients;Journal of Cancer Research and Therapeutics;2024

5. Long-term effectiveness and treatment sequences in patients with extensive stage small cell lung cancer receiving atezolizumab plus chemotherapy: Results of the IFCT-1905 CLINATEZO real-world study;Lung Cancer;2023-11